May 19, 2020 by Christopher Smith, Jennifer Michael and Alan Arville
Epstein Becker Green, pharmacy issues
May 18, 2020, Opinion

On October 17, 2019, the Department of Health and Human Services Office of Inspector General (OIG), published a Proposed Rule providing for new safe harbors under the Anti-Kickback Statute and civil monetary penalty (CMP) law for certain value-based arrangements between various health care stakeholders. The comment period closed on December 31, 2019, and OIG received
May 18, 2020 by Susan Viamari
customer loyalty card
May 18, 2020, Opinion

You are meeting with a key retailer partner tomorrow and you are preparing for your discussion. As your eyes focus in on the report, your mouth falls open. You cannot believe what you are seeing. Your brand, which dominated sales within this category at this retailer for more than a year, is suddenly losing sales
May 18, 2020 by Chain Drug Review
COVID-19, economy
May 18, 2020, News

NEW YORK — The COVID-19 pandemic has not only put a freeze on life as we knew it but on the U.S. economy, which before the outbreak was humming along at a steady pace. With government-imposed lockdowns and social distancing guidelines put in place to slow down the spread of the coronavirus, many businesses have
May 18, 2020 by David Pinto
COVID-19
May 18, 2020, Opinion

There’s an old joke about the time a gun-toting robber confronted the notoriously frugal Jack Benny on the street, demanding “your money or your life.” When Benny failed to respond, the robber, noticeably exasperated, questioned his silence. Responded Benny: “I’m thinking, I’m thinking.” That’s pretty much the dilemma facing the chain drug store business these
May 18, 2020 by Jeffrey Woldt
community pharmacy, coronavirus, COVID-19
May 18, 2020, Opinion

Entrenched assumptions about the role of community pharmacy are being uprooted by the COVID-19 crisis, and leaders of five of the nation’s largest retailers accelerated the process last month during a meeting with President Trump and the Coronavirus Task Force at the White House. The executives were there to lend support to the public-private partnership